Seoul Tista 80/5 mg

Adult dose

The recommended dosage for this medication is one tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time every day (for example, in the morning). In patients with renal impairment, dosage adjustment is not required for mild to moderate renal impairment, but those with severe renal impairment should start at a lower dose and gradually increase. In patients with liver impairment, the daily dose of Telmisartan should not exceed 40 mg for mild or moderate liver impairment.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, and its use is not recommended.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it may cause serious harm to the fetus. It should not be administered to individuals allergic to the active ingredients or similar drugs, pregnant or potentially pregnant women, nursing mothers, patients with obstructive biliary diseases, severe liver disease, specific heart-related conditions, severe hypotension, patients in shock, patients with unstable heart failure following acute myocardial infarction, and patients with certain genetic disorders. Patients with primary aldosteronism or certain heart valve diseases, liver disease, gastrointestinal diseases, renovascular hypertension, dialysis patients, and the elderly should exercise particular caution when using this medication. Various side effects such as dizziness, peripheral edema, palpitations, hypotension, and dyspepsia may occur, and patients should consult healthcare professionals immediately if any unusual symptoms develop. Use of this medication should be avoided during pregnancy, and if pregnancy is confirmed, treatment should be discontinued immediately and switched to another safe therapy. Due to the risk of hypotension, patients with inadequate fluid or salt levels should correct these conditions before administration and monitor blood pressure closely during treatment. Due to the risk of hyperkalemia, blood potassium levels should be regularly monitored, especially when used in combination with high-potassium medications. Patients with impaired renal function should be monitored for changes in renal function while on treatment, and patients with myocardial infarction or angina should be alert for potential worsening of symptoms. Caution is advised while driving or operating machinery as drowsiness or dizziness may occur. This medication may interact with multiple other drugs, so anyone taking other medications should inform their healthcare provider. In the event of overdose, symptoms such as hypotension, dizziness, and heart rhythm irregularities may occur, necessitating immediate medical attention.

Serious side effects

Urticaria, severe swelling (edema), severe allergic reactions, angioedema, angioedema (with potentially fatal results), Stevens-Johnson syndrome, toxic epidermal necrolysis, severe skin reactions, severe edema, markedly reduced urine output, renal impairment (including acute kidney failure), liver function abnormalities, jaundice, hepatitis, severe edema or urinary problems, severe allergic reactions, cardiogenic shock, hemodynamically unstable heart failure following acute myocardial infarction.

Mild side effects

• Dizziness
• peripheral edema
• syncope
• drowsiness
• headache
• sensory disturbances
• taste disturbances
• tremors
• visual disturbances
• vertigo

This medication must be stored in a closed container that is protected from light, at a temperature between 1 degree and 30 degrees Celsius. Proper storage helps to maintain the medication's effectiveness and prevent degradation.

Appearance

White and light gray, biconvex, oval double-coated tablets

Package unit

30 tablets (10 tablets/PTP*3)